PrEP-Rx aims to educate health care providers on PrEP and assist providers in the appropriate targeting of patients at increased risk for HIV, initiating PrEP when appropriate, and providing guidance on the ongoing monitoring and adherence counseling of patients on PrEP. PrEP-Rx aims to serve as an effective intervention that combines innovative technology and client-centered approcahes to reduce the access and disparities currently seen in the realm of PrEP.  

TRUVADA for PrEP is a once-daily prescription medicine that can help reduce the risk of getting HIV-1 through sex, when taken every day and used together with safer sex practices.

PrEP is short for Pre-Exposure Prophylaxis. It means protecting yourself before you come in contact with HIV-1. And continuing to protect yourself by taking the medicine daily and using safer sex practices.  TRUVADA for PrEP is not something you take only when you plan to have sex. And it's not a "morning-after pill." So, there are some things you need to keep in mind before you start the medicine and while you're taking it.

Although Truvada for PrEP has proven to be highly effective, there are still huge gaps in access due to an array of reasons. Several communities of color, women, and other populations are not accessing the medication due to cost, language barriers, or other clinical/social barriers. The prevention of new HIV infections remains a critical public health priority and PrEP is an essential, yet underutilized component of the HIV prevention toolkit. As outcomes of current PrEP formulations in real-world settings and different populations are reported and novel PrEP formulations are introduced, health care providers will continue to require support and guidance to optimize the clinical and public health impact of this valuable HIV prevention strategy.